ArticleNature neuroscience2022
Retraction Note: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma.
RetractedOpen access · bronzeAbstract readRetraction Notice
In one paragraph
Article in Nature neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
40 authors at 11 institutions in 4 countries.
Alexandra GarancherTumor Initiation & Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Hiromichi SuzukiDevelopmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Canada.ORCID http://orcid.org/0000-0002-8858-0294
Svasti HaricharanTumor Microenvironment and Cancer Immunology Program, NCI-Designated Cancer Center and the Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-4471-8853
Lianne Q ChauTumor Initiation & Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Meher Beigi MasihiTumor Initiation & Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Jessica M RusertTumor Initiation & Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Paula S NorrisTumor Microenvironment and Cancer Immunology Program, NCI-Designated Cancer Center and the Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Florent CarretteTumor Microenvironment and Cancer Immunology Program, NCI-Designated Cancer Center and the Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Megan M RomeroDepartment of Pediatrics, Northwestern University, Chicago, IL, USA.
Sorana A MorrissyDevelopmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Canada.ORCID http://orcid.org/0000-0001-8526-562X
Patryk SkowronDevelopmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Canada.
Florence M G CavalliDevelopmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Canada.
Hamza FarooqDevelopmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Canada.
Vijay RamaswamyDivision of Haematology/Oncology and Department of Paediatrics, Hospital for Sick Children, Toronto, Canada.ORCID http://orcid.org/0000-0002-6557-895X
Steven J M JonesCanada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.ORCID http://orcid.org/0000-0003-3394-2208
Richard A MooreCanada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.
Andrew J MungallCanada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.ORCID http://orcid.org/0000-0002-0905-2742
Yussanne MaCanada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.
Nina ThiessenCanada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.
Yisu LiCanada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.
Alaide MorcavalloDivision of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
Lin QiBrain Tumor Program, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Mari KogisoBrain Tumor Program, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Yuchen DuBrain Tumor Program, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Patricia BaxterBrain Tumor Program, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Jacob J HendersonDepartment of Pediatrics, Oregon Health & Science University, Portland, OR, USA.
John R CrawfordDepartments of Pediatrics and Neurosciences, University of California, San Diego - Rady Children's Hospital, San Diego, CA, USA.
Michael L LevyDepartment of Neurosurgery, University of California San Diego - Rady Children's Hospital, San Diego, CA, USA.
James M OlsonClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-5990-6534
Yoon-Jae ChoDepartment of Pediatrics, Oregon Health & Science University, Portland, OR, USA.
Aniruddha J DeshpandeTumor Initiation & Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-5240-9356
Xiao-Nan LiBrain Tumor Program, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Louis CheslerDivision of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.ORCID http://orcid.org/0000-0001-7842-2068
Marco A MarraCanada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.ORCID http://orcid.org/0000-0001-7146-7175
Harald WajantDivision of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
Oren J BecherDepartment of Pediatrics, Northwestern University, Chicago, IL, USA.
Linda M BradleyTumor Microenvironment and Cancer Immunology Program, NCI-Designated Cancer Center and the Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Carl F WareTumor Microenvironment and Cancer Immunology Program, NCI-Designated Cancer Center and the Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Michael D TaylorDevelopmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Canada.ORCID http://orcid.org/0000-0001-7009-3466
Robert J Wechsler-ReyaTumor Initiation & Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. rwreya@sbpdiscovery.org.ORCID http://orcid.org/0000-0002-7463-8352
Sanford Burnham Prebys Medical Discovery Institute · USCanada's Michael Smith Genome Sciences Centre · CAHospital for Sick Children · CABaylor College of Medicine · USInstitute of Cancer Research · GBNorthwestern University · USOregon Health & Science University · USUniversity of California San Diego · USFred Hutch Cancer Center · USUniversitätsklinikum Würzburg · DEUniversity of Calgary · CA
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.